CBD shows promise for social anxiety in small trial
NCT ID NCT05571592
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether cannabidiol (CBD), a compound from the cannabis plant, can reduce symptoms of social anxiety disorder. Sixty adults with moderate to severe social anxiety took either a high dose of CBD, a lower dose, or a placebo pill twice daily for three weeks. Researchers measured changes in anxiety during a stress task, brain activity using fMRI, and clinician-rated social anxiety scores to see if CBD had a calming effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an AI coach help therapists treat depression and anxiety online?
- Can a unified therapy tame both addiction and emotional disorders?
- Can learning Self-Compassion quiet anxiety and depression?
- A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test
- Can a phone app retrain your brain to ease social anxiety?
- Could a single brain target treat depression, anxiety, and OCD at once?